Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125136372 | 12513637 | 2 | F | 20151115 | 20160628 | 20160630 | 20160713 | EXP | US-JNJFOC-20160508053 | JANSSEN | 88.07 | YR | E | M | Y | 0.00000 | 20160713 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125136372 | 12513637 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
125136372 | 12513637 | 2 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 22406 | 15 | MG | TABLET | |||||
125136372 | 12513637 | 3 | SS | TYLENOL | ACETAMINOPHEN | 1 | Oral | U | U | UNKNOWN | 19872 | UNSPECIFIED | |||||||
125136372 | 12513637 | 4 | SS | TYLENOL | ACETAMINOPHEN | 1 | Oral | U | U | UNKNOWN | 19872 | UNSPECIFIED | |||||||
125136372 | 12513637 | 5 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | Y | 0 | UNSPECIFIED | |||||||||
125136372 | 12513637 | 6 | C | COREG | CARVEDILOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125136372 | 12513637 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125136372 | 12513637 | 8 | C | LASIX | FUROSEMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125136372 | 12513637 | 9 | C | NAMENDA | MEMANTINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125136372 | 12513637 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125136372 | 12513637 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125136372 | 12513637 | 1 | Thrombosis prophylaxis |
125136372 | 12513637 | 2 | Thrombosis prophylaxis |
125136372 | 12513637 | 4 | Product used for unknown indication |
125136372 | 12513637 | 5 | Product used for unknown indication |
125136372 | 12513637 | 6 | Hypertension |
125136372 | 12513637 | 7 | Hypertension |
125136372 | 12513637 | 8 | Cardiac failure congestive |
125136372 | 12513637 | 9 | Dementia |
125136372 | 12513637 | 10 | Hypothyroidism |
125136372 | 12513637 | 11 | Gastrooesophageal reflux disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125136372 | 12513637 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125136372 | 12513637 | Acute kidney injury | |
125136372 | 12513637 | Anaemia | |
125136372 | 12513637 | Ear haemorrhage | |
125136372 | 12513637 | Internal haemorrhage | |
125136372 | 12513637 | Renal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125136372 | 12513637 | 1 | 201506 | 20151115 | 0 | |
125136372 | 12513637 | 2 | 201506 | 20151115 | 0 |